{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:20:55Z","timestamp":1775715655174,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pheochromocytoma and paraganglioma caused by succinate dehydrogenase gene mutations is called hereditary pheochromocytoma\/paraganglioma syndrome. In particular, succinate dehydrogenase subunit B mutations are important because they are strongly associated with the malignant behavior of pheochromocytoma and paraganglioma . This is a case report of a family of hereditary pheochromocytoma\/paraganglioma syndrome carrying a novel mutation in succinate dehydrogenase subunit B.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 19-year-old Japanese woman, whose father died of metastatic paraganglioma, was diagnosed with abdominal paraganglioma, and underwent total resection. Succinate dehydrogenase subunit B genetic testing detected a splice-site mutation, c.424-2delA, in her germline and paraganglioma tissue. Afterwards, the same succinate dehydrogenase subunit B mutation was detected in her father\u2019s paraganglioma tissues.<jats:italic>In silico<\/jats:italic>analysis predicted the mutation as \u201cdisease causing.\u201d She is under close follow-up, and no recurrence or metastasis has been observed for 4\u00a0years since surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We detected a novel succinate dehydrogenase subunit B mutation, c.424-2delA, in a Japanese family afflicted with hereditary pheochromocytoma\/paraganglioma syndrome and found the mutation to be responsible for hereditary pheochromocytoma\/paraganglioma syndrome. This case emphasizes the importance of performing genetic testing for patients with pheochromocytoma and paraganglioma suspected of harboring the succinate dehydrogenase subunit B mutation (that is, metastatic, extra-adrenal, multiple, early onset, and family history of pheochromocytoma and paraganglioma) and offer surveillance screening to mutation carriers.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-021-02852-z","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T23:05:42Z","timestamp":1621638342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hereditary pheochromocytoma\/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two\u00a0case reports"],"prefix":"10.1186","volume":"15","author":[{"given":"Rei","family":"Hirose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-3286","authenticated-orcid":false,"given":"Yuya","family":"Tsurutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiho","family":"Sugisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Yonamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takekoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,22]]},"reference":[{"key":"2852_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrendo.2014.188","volume":"11","author":"J Favier","year":"2015","unstructured":"Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol. 2015;11:101\u201311.","journal-title":"Nat Rev Endocrinol"},{"key":"2852_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PL Dahia","year":"2014","unstructured":"Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014;14:108\u201319.","journal-title":"Nat Rev Cancer"},{"key":"2852_CR3","first-page":"5615","volume":"63","author":"AP Gimenez-Roqueplo","year":"2003","unstructured":"Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, et\u00a0al. Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Res. 2003;63:5615\u201321.","journal-title":"Cancer Res"},{"key":"2852_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2005-1862","volume":"91","author":"DE Benn","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, et\u00a0al. Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91:827\u201336.","journal-title":"J Clin Endocrinol Metab"},{"key":"2852_CR5","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1210\/jc.2006-0423","volume":"91","author":"FM Brouwers","year":"2006","unstructured":"Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, et\u00a0al. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab. 2006;91:4505\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"2852_CR6","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2007-0709","volume":"92","author":"L Amar","year":"2007","unstructured":"Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, et\u00a0al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab. 2007;92:3822\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2852_CR7","doi-asserted-by":"publisher","first-page":"T91","DOI":"10.1530\/ERC-15-0268","volume":"22","author":"DE Benn","year":"2015","unstructured":"Benn DE, Robinson BG, Clifton-Bligh RJ. 15 Years of paraganglioma: clinical manifestations of paraganglioma syndromes types 1\u20135. Endocr Relat Cancer. 2015;22:T91-103.","journal-title":"Endocr Relat Cancer"},{"key":"2852_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1737","volume":"5","author":"E Gottlieb","year":"2005","unstructured":"Gottlieb E, Tomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer. 2005;5:857\u201366.","journal-title":"Nat Rev Cancer"},{"key":"2852_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/PAT.0b013e3283539932","volume":"44","author":"AJ Gill","year":"2012","unstructured":"Gill AJ. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology. 2012;44:285\u201392.","journal-title":"Pathology"},{"key":"2852_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s11064-015-1738-3","volume":"41","author":"Y Saito","year":"2016","unstructured":"Saito Y, Ishii KA, Aita Y, Ikeda T, Kawakami Y, Shimano H, et\u00a0al. Loss of SDHB elevates catecholamine synthesis and secretion depending on ROS production and HIF stabilization. Neurochem Res. 2016;41:696\u2013706.","journal-title":"Neurochem Res"},{"key":"2852_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12672-012-0113-y","volume":"3","author":"A Weber","year":"2012","unstructured":"Weber A, Hoffmann MM, Neumann HP, Erlic Z. Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma. Horm Cancer. 2012;3:187\u201392.","journal-title":"Horm Cancer"},{"key":"2852_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/35101031","volume":"1","author":"AG Knudson","year":"2001","unstructured":"Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer. 2001;1:157\u201362.","journal-title":"Nat Rev Cancer"},{"key":"2852_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/ERC-13-0494","volume":"21","author":"N Kimura","year":"2014","unstructured":"Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, et\u00a0al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer. 2014;21:405\u201314.","journal-title":"Endocr Relat Cancer"},{"key":"2852_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","volume":"10","author":"FH van Nederveen","year":"2009","unstructured":"van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, et\u00a0al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009;10:764\u201371.","journal-title":"Lancet Oncol"},{"key":"2852_CR15","doi-asserted-by":"publisher","first-page":"L13","DOI":"10.1530\/ERC-13-0530","volume":"21","author":"N Kimura","year":"2014","unstructured":"Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, Oki Y, et\u00a0al. Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer. 2014;21:L13\u20136.","journal-title":"Endocr Relat Cancer"},{"key":"2852_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1507\/endocrj.K08E-178","volume":"56","author":"T Saito","year":"2009","unstructured":"Saito T, Saito Y, Matsumura K, Tsubota Y, Maniwa T, Kaneda H, et\u00a0al. Novel mutation (L157X) in the succinate dehydrogenase B gene (SDHB) in a Japanese family with abdominal paraganglioma following lung metastasis. Endocr J. 2009;56:451\u20138.","journal-title":"Endocr J"},{"key":"2852_CR17","unstructured":"Splice Site Prediction. https:\/\/www.fruitfly.org\/seq_tools\/splice.html. Accessed 22 November 2020."},{"key":"2852_CR18","unstructured":"NetGene2. http:\/\/www.cbs.dtu.dk\/services\/NetGene2\/. Accessed 22 November 2020."},{"key":"2852_CR19","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.jid.2016.05.128","volume":"136","author":"DY Jin","year":"2016","unstructured":"Jin DY, Vermeer C, Stafford DW, Tie JK. Splice-site mutation of exon 3 deletion in the gamma-glutamyl carboxylase gene causes inactivation of the enzyme. J Invest Dermatol. 2016;136:2314\u20137.","journal-title":"J Invest Dermatol"},{"key":"2852_CR20","unstructured":"Mutation Taster. http:\/\/www.mutationtaster.org\/. Accessed 22 November 2020."},{"key":"2852_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2350-6-39","volume":"6","author":"JP Bayley","year":"2005","unstructured":"Bayley JP, Devilee P, Taschner PE. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet. 2005;6:39.","journal-title":"BMC Med Genet"},{"key":"2852_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2350-10-34","volume":"10","author":"JP Bayley","year":"2009","unstructured":"Bayley JP, Grimbergen AE, van Bunderen PA, van der Wielen M, Kunst HP, Lenders JW, et\u00a0al. The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients. BMC Med Genet. 2009;10:34.","journal-title":"BMC Med Genet"},{"key":"2852_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1530\/EJE-17-0074","volume":"177","author":"ND Niemeijer","year":"2017","unstructured":"Niemeijer ND, Rijken JA, Eijkelenkamp K, van der Horst-Schrivers ANA, Kerstens MN, Tops CMJ, et\u00a0al. The phenotype of SDHB germline mutation carriers: a nationwide study. Eur J Endocrinol. 2017;177:115\u201325.","journal-title":"Eur J Endocrinol"},{"key":"2852_CR24","doi-asserted-by":"publisher","first-page":"T201","DOI":"10.1530\/ERC-18-0085","volume":"25","author":"HP Neumann","year":"2018","unstructured":"Neumann HP, Young WF, Krauss T, Bayley JP, Schiavi F, Opocher G, et\u00a0al. 65 years of the double helix: genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocr Relat Cancer. 2018;25:T201\u201319.","journal-title":"Endocr Relat Cancer"},{"key":"2852_CR25","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00432-017-2397-3","volume":"143","author":"I Jochmanova","year":"2017","unstructured":"Jochmanova I, Wolf KI, King KS, Nambuba J, Wesley R, Martucci V, et\u00a0al. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations. J Cancer Res Clin Oncol. 2017;143:1421\u201335.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2852_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/cge.13055","volume":"93","author":"JA Rijken","year":"2018","unstructured":"Rijken JA, Niemeijer ND, Jonker MA, Eijkelenkamp K, Jansen JC, van Berkel A, et\u00a0al. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers. Clin Genet. 2018;93:60\u20136.","journal-title":"Clin Genet"},{"key":"2852_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/ERC-11-0243","volume":"19","author":"JS Fonte","year":"2012","unstructured":"Fonte JS, Robles JF, Chen CC, Reynolds J, Whatley M, Ling A, et\u00a0al. False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocr Relat Cancer. 2012;19:83\u201393.","journal-title":"Endocr Relat Cancer"},{"key":"2852_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","volume":"21","author":"PD Stenson","year":"2003","unstructured":"Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et\u00a0al. Human gene mutation database (HGMD): 2003 update. Hum Mutat. 2003;21:577\u201381.","journal-title":"Hum Mutat"},{"key":"2852_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1507\/endocrj.K07-087","volume":"55","author":"K Takekoshi","year":"2008","unstructured":"Takekoshi K, Isobe K, Suzuki H, Nissato S, Kawakami Y, Kawai K, et\u00a0al. R46Q mutation in the succinate dehydrogenase B gene (SDHB) in a Japanese family with both abdominal and thoracic paraganglioma following metastasis. Endocr J. 2008;55:299\u2013303.","journal-title":"Endocr J"},{"key":"2852_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2006-2315","volume":"92","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, et\u00a0al. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007;92:779\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"2852_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","volume":"55","author":"KA Andrews","year":"2018","unstructured":"Andrews KA, Ascher DB, Pires DEV, Barnes DR, Vialard L, Casey RT, et\u00a0al. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB SDHC and SDHD. J Med Genet. 2018;55:384\u201394.","journal-title":"J Med Genet"},{"key":"2852_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1530\/EC-18-0522","volume":"8","author":"N Tufton","year":"2019","unstructured":"Tufton N, Shapiro L, Sahdev A, Kumar AV, Martin L, Drake WM, et\u00a0al. An analysis of surveillance screening for SDHB-related disease in childhood and adolescence. Endocr Connect. 2019;8:162\u201372.","journal-title":"Endocr Connect"},{"key":"2852_CR33","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et\u00a0al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"2852_CR34","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"PF Plouin","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, et\u00a0al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016;174:G1\u201310.","journal-title":"Eur J Endocrinol"},{"key":"2852_CR35","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.3747\/co.21.1579","volume":"21","author":"M Lefebvre","year":"2014","unstructured":"Lefebvre M, Foulkes WD. Pheochromocytoma and paraganglioma syndromes: genetics and management update. Curr Oncol. 2014;21:e8\u201317.","journal-title":"Curr Oncol"},{"key":"2852_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cen.13926","volume":"90","author":"MY Wong","year":"2019","unstructured":"Wong MY, Andrews KA, Challis BG, Park SM, Acerini CL, Maher ER, et\u00a0al. Clinical Practice Guidance: surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers. Clin Endocrinol (Oxf). 2019;90:499\u2013505.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2852_CR37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/joim.12869","volume":"285","author":"A Muth","year":"2019","unstructured":"Muth A, Crona J, Gimm O, Elmgren A, Filipsson K, Stenmark Askmalm M, et\u00a0al. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma. J Intern Med. 2019;285:187\u2013204.","journal-title":"J Intern Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02852-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02852-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02852-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T01:26:32Z","timestamp":1699061192000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02852-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,22]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2852"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02852-z","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,22]]},"assertion":[{"value":"14 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the fundamental principles of the Declaration of Helsinki. Written informed consent was obtained from \u201cpatient 1\u201d and the wife of \u201cpatient 2\u201d before submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient and next of kin of the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}